Current Trends in the Management of Richter's Syndrome

Overview

Journal Int J Hematol Oncol

Date 2019 Jan 18

PMID 30651968

Citations 24

Authors

John N Allan

Richard R Furman

Affiliations

Soon will be listed here.

Abstract

Richter's syndrome (RS) is a life-threatening complication of chronic lymphocytic leukemia (CLL). While previous research has increased our knowledge on the distinct evolutionary patterns of RS and provided a deeper understanding of the risk factors and molecular events predisposing to transformation, there remain few targetable aberrations and treatment is largely ineffective. The ability to obtain deeper remissions, without selecting for deletion 17p, by using novel B-cell receptor (BCR) antagonists and bcl2 inhibition might lead to a decrease in the incidence of RS, but these agents have done little to significantly change outcomes when incorporated into treatment regimens for RS. In this review we highlight the current landscape of molecular lesions specific to RS, review the data on historical treatment options, and look to the horizon for potential opportunities in the future.

Citing Articles

An extranodal Richter's syndrome presenting with cardiac diffuse large B-cell lymphoma: a case report.

Wang H, Yan W, Sun J, Dong M, Zhang N, Liu T BMC Cardiovasc Disord. 2023; 23(1):624.

PMID: 38129785 PMC: 10740268. DOI: 10.1186/s12872-023-03663-4.

Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.

Czader M, Amador C, Cook J, Thakkar D, Parker C, Dave S Am J Clin Pathol. 2023; 159(6):554-571.

PMID: 37052539 PMC: 10233402. DOI: 10.1093/ajcp/aqad027.

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.

Ten Hacken E, Sewastianik T, Yin S, Hoffmann G, Gruber M, Clement K Blood Cancer Discov. 2022; 4(2):150-169.

PMID: 36468984 PMC: 9975769. DOI: 10.1158/2643-3230.BCD-22-0082.

Lung Adenocarcinoma with Chronic Lymphocytic Leukemia Mimicking Bone Metastasis.

Matsuoka T, Miyazaki A, Kosai S, Nakamura K, Uramoto H, Kobayashi H Intern Med. 2022; 62(12):1801-1806.

PMID: 36351574 PMC: 10332956. DOI: 10.2169/internalmedicine.0112-22.

A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma.

Sato K, Imamura H, Watahiki Y, Hazama H, Hashimoto T, Mukae S Intern Med. 2022; 62(11):1611-1615.

PMID: 36261374 PMC: 10293001. DOI: 10.2169/internalmedicine.0420-22.

References

Mauro F, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E . Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood. 1999; 94(2):448-54. View

Hamblin T, Davis Z, Gardiner A, Oscier D, Stevenson F . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999; 94(6):1848-54. View

KANZLER H, Kuppers R, Helmes S, Wacker H, Chott A, Hansmann M . Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood. 2000; 95(3):1023-31. View

van den Berg A, Maggio E, Rust R, Kooistra K, Diepstra A, Poppema S . Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood. 2002; 100(4):1425-9. View

LORTHOLARY P, Boiron M, RIPAULT P, LEVY J, MANUS A, Bernard J . [CHRONIC LYMPHOID LEUKEMIA SECONDARILY ASSOCIATED WITH A MALIGNANT RETICULOPATHY: RICHTER'S SYNDROME]. Nouv Rev Fr Hematol. 1964; 4:621-44. View

Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M . Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004; 113(7):1008-16. PMC: 379317. DOI: 10.1172/JCI19399. View

Tsimberidou A, OBrien S, Khouri I, Giles F, Kantarjian H, Champlin R . Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol. 2006; 24(15):2343-51. DOI: 10.1200/JCO.2005.05.0187. View

Bruzzi J, Macapinlac H, Tsimberidou A, Truong M, Keating M, Marom E . Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med. 2006; 47(8):1267-73. View

Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T . Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 2006; 109(1):259-70. DOI: 10.1182/blood-2006-03-012948. View

10.

Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C . IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol. 2007; 31(10):1605-14. DOI: 10.1097/PAS.0b013e31804bdaf8. View

11.

Rossi D, Cerri M, Capello D, Deambrogi C, Rossi F, Zucchetto A . Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol. 2008; 142(2):202-15. DOI: 10.1111/j.1365-2141.2008.07166.x. View

12.

Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M . Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia. 2009; 23(6):1062-72. DOI: 10.1038/leu.2008.399. View

13.

Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L . Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res. 2009; 15(13):4415-22. DOI: 10.1158/1078-0432.CCR-08-3266. View

14.

Darzentas N, Hadzidimitriou A, Murray F, Hatzi K, Josefsson P, Laoutaris N . A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia. 2009; 24(1):125-32. DOI: 10.1038/leu.2009.186. View

15.

Fraser C, Wang W, Gomez M, Zhang T, Mathew S, Furman R . Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. Am J Clin Pathol. 2009; 132(6):928-39. DOI: 10.1309/AJCPWQ0I0DGXBMHO. View

16.

Richter M . Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia. Am J Pathol. 2009; 4(4):285-292.7. PMC: 2006994. View

17.

Scandurra M, Rossi D, Deambrogi C, Rancoita P, Chigrinova E, Mian M . Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas. Hematol Oncol. 2009; 28(2):62-7. DOI: 10.1002/hon.932. View

18.

Duong T, Grange F, Auffret N, Aractingi S, Bodemer C, Brousse N . Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature. Dermatology. 2010; 220(3):226-33. DOI: 10.1159/000269737. View

19.

Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D . Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica. 2010; 95(9):1526-33. PMC: 2930954. DOI: 10.3324/haematol.2010.022277. View

20.

Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K . The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood. 2011; 117(12):3391-401. DOI: 10.1182/blood-2010-09-302174. View